| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
23,204 |
18,593 |
$738K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
13,114 |
11,334 |
$548K |
| S8301 |
Infection control supplies, not otherwise specified |
13,302 |
11,314 |
$343K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,094 |
3,784 |
$301K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,061 |
4,455 |
$217K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
10,938 |
9,748 |
$140K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
10,024 |
4,535 |
$126K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
8,585 |
7,418 |
$122K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
15,175 |
13,247 |
$89K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,051 |
963 |
$80K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,781 |
2,448 |
$62K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
681 |
644 |
$51K |
| 99000 |
|
5,351 |
5,079 |
$48K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,903 |
2,598 |
$37K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
677 |
654 |
$36K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
436 |
410 |
$27K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,634 |
2,502 |
$25K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,805 |
1,666 |
$19K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
503 |
454 |
$19K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,113 |
1,119 |
$17K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
339 |
320 |
$17K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
195 |
188 |
$14K |
| 84480 |
|
1,321 |
1,226 |
$12K |
| 80061 |
Lipid panel |
2,053 |
1,934 |
$11K |
| 84439 |
|
1,706 |
1,570 |
$10K |
| 99050 |
|
734 |
645 |
$9K |
| 92588 |
|
579 |
542 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,634 |
1,528 |
$7K |
| 78268 |
|
89 |
88 |
$6K |
| 99091 |
|
130 |
129 |
$6K |
| 81003 |
|
3,439 |
3,083 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
500 |
448 |
$5K |
| 99215 |
Prolong outpt/office vis |
123 |
110 |
$5K |
| 90756 |
|
294 |
272 |
$4K |
| 82947 |
|
1,294 |
1,186 |
$3K |
| 82044 |
|
1,619 |
1,524 |
$3K |
| 82570 |
|
1,617 |
1,519 |
$3K |
| 81025 |
|
298 |
286 |
$2K |
| 96160 |
|
974 |
916 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,856 |
1,678 |
$2K |
| 96156 |
|
60 |
53 |
$1K |
| 99490 |
Ccm add 20min |
2,044 |
1,733 |
$1K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
141 |
110 |
$1K |
| G0315 |
Immunization counseling by a physician or other qualified health care professional for covid-19, ages under 21, 5-15 mins time (this code is used for the medicaid early and periodic screening, diagnostic, and treatment benefit (epsdt) |
52 |
49 |
$1K |
| 0071A |
|
27 |
27 |
$1K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
13 |
13 |
$981.21 |
| 90620 |
|
245 |
234 |
$962.00 |
| 78267 |
|
88 |
87 |
$740.06 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
866 |
792 |
$617.80 |
| 97169 |
|
48 |
43 |
$564.00 |
| 0012A |
|
52 |
49 |
$454.24 |
| A4245 |
Alcohol wipes, per box |
1,453 |
1,220 |
$432.23 |
| 93000 |
|
42 |
41 |
$422.72 |
| 0011A |
|
51 |
51 |
$287.98 |
| 90674 |
|
53 |
43 |
$236.82 |
| 0013A |
|
13 |
13 |
$200.00 |
| 90734 |
|
186 |
174 |
$150.23 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
12 |
12 |
$86.58 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
76 |
68 |
$59.21 |
| 96161 |
|
74 |
70 |
$44.64 |
| 36415 |
Collection of venous blood by venipuncture |
2,291 |
2,033 |
$11.70 |
| 90686 |
|
642 |
618 |
$0.64 |
| 90651 |
|
354 |
341 |
$0.07 |
| 99401 |
|
3,801 |
3,037 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
2,697 |
2,067 |
$0.00 |
| 99051 |
|
1,846 |
1,568 |
$0.00 |
| 90715 |
|
33 |
33 |
$0.00 |
| 90670 |
|
44 |
43 |
$0.00 |
| 36416 |
|
2,052 |
1,774 |
$0.00 |
| 96127 |
|
87 |
76 |
$0.00 |
| 91307 |
|
47 |
40 |
$0.00 |
| 91301 |
|
39 |
37 |
$0.00 |
| 99496 |
|
13 |
12 |
$0.00 |
| G0136 |
Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months |
110 |
104 |
$0.00 |